Detalhe da pesquisa
1.
Deep Learning-Based H-Score Quantification of Immunohistochemistry-Stained Images.
Mod Pathol
; 37(2): 100398, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38043788
2.
Circulating microRNA Panel for Prediction of Recurrence and Survival in Early-Stage Lung Adenocarcinoma.
Int J Mol Sci
; 25(4)2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38397007
3.
Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non-Small Cell Lung Cancer.
Mod Pathol
; 36(1): 100028, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788067
4.
Augmented Lipocalin-2 Is Associated with Chronic Obstructive Pulmonary Disease and Counteracts Lung Adenocarcinoma Development.
Am J Respir Crit Care Med
; 203(1): 90-101, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32730093
5.
CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma.
Cancer Immunol Immunother
; 70(7): 1965-1976, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33416944
6.
Interplay between estrogen and Stat3/NF-κB-driven immunomodulation in lung cancer.
Carcinogenesis
; 41(11): 1529-1542, 2020 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32603404
7.
18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer.
Cancer Immunol Immunother
; 69(8): 1519-1534, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32300858
8.
Driver Mutations in Normal Airway Epithelium Elucidate Spatiotemporal Resolution of Lung Cancer.
Am J Respir Crit Care Med
; 200(6): 742-750, 2019 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30896962
9.
YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib.
Am J Respir Crit Care Med
; 200(7): 888-899, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31166114
10.
5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging.
Thorax
; 74(4): 371-379, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30472670
11.
A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients.
J Pathol
; 245(4): 421-432, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29756233
12.
Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome.
Proc Natl Acad Sci U S A
; 113(11): E1555-64, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26929325
13.
The oncogenic RNA-binding protein SRSF1 regulates LIG1 in non-small cell lung cancer.
Lab Invest
; 98(12): 1562-1574, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30181552
14.
Multiregion gene expression profiling reveals heterogeneity in molecular subtypes and immunotherapy response signatures in lung cancer.
Mod Pathol
; 31(6): 947-955, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29410488
15.
Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment.
Proc Natl Acad Sci U S A
; 112(25): 7779-84, 2015 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-26056316
16.
Interleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung Cancer: Analysis of Clinical Samples and BMTP-11 Preclinical Activity.
Am J Pathol
; 186(8): 2162-2170, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27317903
17.
ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers.
Proc Natl Acad Sci U S A
; 111(41): 14788-93, 2014 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25267614
18.
Correction to: CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma.
Cancer Immunol Immunother
; 70(7): 1977-1978, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33686493
19.
Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations.
BMC Genomics
; 16: 752, 2015 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26444668
20.
Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights.
Nat Commun
; 15(1): 3152, 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38605064